Back to VRTX overview

VRTX Vertex Pharmaceuticals PE ratio, current and historical analysis

As of Jun 20, 2024, the VRTX stock has a PE ratio of 30.26. The calculation is based on the latest EPS of $15.58 and the stock price of $471.38 per share. An increase of 12% has been observed in the PE ratio compared to its average of 27.1 of the past four quarters.

VRTX PE ratio history

How has VRTX's PE ratio performed in the past

The mean historical PE ratio of Vertex Pharmaceuticals over the last eight years is 53.28. The current 30.26 price-to-earnings ratio is 43% less than the historical average. Analyzing the last eight years, VRTX's PE ratio reached its highest point in the Sep 2017 quarter at 190.05, with a price of $152.04 and an EPS of $0.8. The Dec 2018 quarter saw the lowest point at 20.11, with a price of $165.71 and an EPS of $8.24.


Vertex Pharmaceuticals PE ratio by year

Maximum annual increase: 137.74% in 2019

Maximum annual decrease: -85.78% in 2018

Year PE ratio Change
2023 28.96 30.04%
2022 22.27 -7.82%
2021 24.16 6.71%
2020 22.64 -52.65%
2019 47.81 137.74%
2018 20.11 -85.78%
2017 141.38 N/A
2016 N/A N/A
2015 N/A N/A
2014 N/A N/A

VRTX average PE ratio chart

What is the average PE ratio of VRTX for the past years

VRTX's current PE ratio is higher than the 3 and 5-year averages, but it is under its 10-year average.

3-year avg
5-year avg
10-year avg
15-year avg

VRTX PE vs peers

What is VRTX's PE ratio compared to its peers

When compared to its peers MRK and ABBV, VRTX's PE ratio is lower, but it is higher than JNJ's and ENZN's.

Stock name PE ratio Market cap
ENZN Enzon Pharmaceuticals Inc 0.5 $7.96M
JNJ Johnson & Johnson 9.75 $357.99B
VRTX Vertex Pharmaceuticals Inc 30.04 $120.77B
ABBV AbbVie Inc 50.56 $300.89B
MRK Merck & Co Inc 143.65 $331.09B
GILD Gilead Sciences Inc 176.61 $88.01B
BMY Bristol Myers Squibb Co N/A $85B
ENTA Enanta Pharmaceuticals Inc N/A $252.88M

Frequently asked questions

What is Vertex Pharmaceuticals's PE ratio?

The price to earnings ratio for VRTX stock is 30.26 as of Jun 20, 2024.

What is the 3-year average PE ratio for Vertex Pharmaceuticals (VRTX)?

Over the last 3 years, the average PE ratio for VRTX stock is 25.0.

What is the 5-year average PE ratio for Vertex Pharmaceuticals (VRTX)?

Over the last 5 years, the average PE ratio for VRTX stock is 26.76.

What is the highest PE ratio for VRTX?

The highest quarterly PE ratio in the last eight years has been 190.05 and it was in the Sep 2017 quarter.

How does the current PE ratio for VRTX compare to its historical average?

VRTX's current price to earnings ratio is 43% below its 8-year historical average.

How is VRTX's PE ratio calculated (Vertex Pharmaceuticals PE ratio formula)?

The P/E ratio is calculated by taking the latest stock price and dividing it by the earnings per share(EPS) for the last 12 months. As of today (Jun 20, 2024), Vertex Pharmaceuticals's share price is $471.38. The company's earnings per share for the trailing twelve months (TTM) ending Mar 2024 is $15.58. Therefore, Vertex Pharmaceuticals's price to earnings ratio for today is 30.26. PE RATIO(30.26) = STOCK PRICE($471.38) / TTM EPS($15.58)

All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.